Top compounds associated with response to CTC-260F20.3


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.02
mRNA MS-275 CTRPv2 pan-cancer AAC -0.08 0.02
mRNA COL-3 CTRPv2 pan-cancer AAC 0.089 0.02
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.082 0.02
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.084 0.02
mRNA ML320 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA BRD-M00053801 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.084 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.03
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.084 0.03
Download CSV